A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA deadline for compound pharmacies to stop making it is in place.

As GLP-1 medications such as Ozempic, Mounjaro and Wegovy rise in popularity, so do concerns over their side effects.

UT Health San Antonio is commemorating Diabetes Alert Day on March 28 by providing the following question and answer session regarding diabetes and obesity with Carolina Solis-Herrera, MD.